CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;Université Nice Sophia Antipolis;INSERM (Institut National de la Santé et de la Recherche Médicale);Centre Scientifique de Monaco
发明人:
申请号：
EP16305943.9
公开号：
EP3272771A1
申请日:
2016.07.22
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present disclosure relates to an anti-VEGFC antibody for use for preventing the occurrence of new metastases or the development of existing metastases in a subject exposed to or who will be exposed to a cancer treatment inducing p38 activation. The present disclosure in addition provides methods for selecting a treatment of interest, as well as pharmaceutical compositions, kits, and uses thereof.
